Evidence map›Paper›PMID 32366602›Full record

ArticleSexually transmitted infections2021

Characterising HIV and STIs among transgender female sex workers: a longitudinal analysis.

Tonia Poteat, Rebecca Hamilton White, Katherine H A Footer, Ju Nyeong Park, Noya Galai, Steven Huettner, Brad E Silberzahn, Sean T Allen, Jennifer Glick, S Wilson Beckham and 2 more

Open access · greenAbstract read
In one paragraph

Article in Sexually transmitted infections, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Characterizing Arrest and Incarceration in a Prospective Cohort of Transgender Women.Journal of correctional health care : the official journal of the National Commission on Correctional Health Care · 2023
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Tonia PoteatDepartment of Social Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA tonia_poteat@med.unc.edu.ORCID 0000-0001-6541-3787
Rebecca Hamilton WhiteDepartment of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Katherine H A FooterDepartment of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Ju Nyeong ParkDepartment of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Noya GalaiDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Steven HuettnerDepartment of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Brad E SilberzahnDepartment of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Sean T AllenDepartment of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Jennifer GlickDepartment of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
S Wilson BeckhamDepartment of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Charlotte A GaydosDivision of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland, USA.
Susan G ShermanDepartment of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Johns Hopkins University · USUniversity of North Carolina at Chapel Hill · US

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
QAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7M
TrainingU54EB007958 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI William Owen Osburn · 2007 to 2026
$34.6M
NIDA Epidemiology Training Program: Johns Hopkins UniversityT32DA007292 · NIDA · JOHNS HOPKINS UNIVERSITY · PI RENEE M. JOHNSON, Brion S Maher · 1993 to 2026
$17.7M
HIV Prevention Trials Network: Network LaboratoryU01AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ESHLEMAN, SUSAN H · 2006 to 2010
$16.5M
Institute for Clinical and Translational ResearchKL2TR001077 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$9.2M
Training Program for Scientists Conducting Research to Reduce HIV Health DisparitR25MH067127 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Emily A Arnold, Torsten Brian Neilands · 2003 to 2026
$5.4M
The HIV risk environment of high-risk women: Interaction with public safetyR01DA038499 · NIDA · JOHNS HOPKINS UNIVERSITY · PI SHERMAN, SUSAN G. · 2015 to 2018
$2.8M
An Examination of the Joint Contributions of Socioeconomic Disadvantage, Genetics, and COVID-19 on the Development of Delay Discounting and Substance Use Across AdolescenceR01DA057552 · NIDA · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI JULIA W FELTON, Brion S Maher · 2022 to 2026
$1.8M
Preferences for PrEP in Tanzanian Women at Heightened Risk of HIV InfectionK01MH114715 · NIMH · JOHNS HOPKINS UNIVERSITY · PI COLE, SAM WILSON · 2017 to 2021
$732k
Syringe Services Program Implementation in Rural Counties Vulnerable to HIV OutbreakK01DA046234 · NIDA · JOHNS HOPKINS UNIVERSITY · PI ALLEN, SEAN T · 2018 to 2022
$722k
NCATS NIH HHS KL2 TR001077NCATS NIH HHS UL1 TR003098NIAID NIH HHS P30 AI094189NIAID NIH HHS U01 AI068613NIBIB NIH HHS U54 EB007958NIDA NIH HHS K01 DA046234NIDA NIH HHS R01 DA038499NIDA NIH HHS R01 DA057552NIDA NIH HHS T32 DA007292NIMH NIH HHS K01 MH114715NIMH NIH HHS R25 MH067127
6 · The paper itself

Abstract

objectivesThough highly vulnerable to HIV and STIs, transgender female sex workers (TFSWs) are understudied in the US HIV and STI response. This study examined the correlates of laboratory-confirmed STIs among a cohort of 62 TFSWs followed over the course of 1 year and explored associations between specimen site and self-reported engagement in insertive and receptive anal intercourse.

methodsParticipants completed an interviewer-administered computer-assisted personal interview at baseline, 3-, 6-, 9- and 12-month visits where self-administered anal swabs and urine samples for gonorrhea, chlamydia and trichomoniasis were also collected. HIV testing was conducted at baseline, 6-month and 12-month visits.

resultsBaseline HIV prevalence was 40.3% with no HIV seroconversions over follow-up. Baseline prevalence of gonorrhea, chlamydia and trichomoniasis was 9.7%, 17.7% and 14.5%, respectively. In the multivariable regression modelling, recent arrest was significantly associated with testing positive for any STI (adjusted risk ratio (RR) 1.77; 95% CI: 1.10 to 2.84). Insertive anal sex with clients was associated with increased risk of testing positive for an STI via urine specimen (RR 3.48; 95% CI: 1.14 to 10.62), while receptive anal sex was not significantly associated with specimen site.

conclusionOur findings confirm a high prevalence of STIs among TFSWs and highlight the importance of addressing structural drivers such as criminal justice involvement as well as the need to ensure screening for STIs at all anatomical sites regardless of self-reported sites of potential exposure. More research is needed to better understand HIV and STI vulnerabilities and appropriate interventions for TFSWs in the USA.

Indexed as

AdolescentAdultFemaleHIV InfectionsHumansLongitudinal StudiesMaleProspective StudiesSexually Transmitted DiseasesSex WorkersTransgender PersonsUnsafe SexYoung Adultchlamydia infectioncommercial sexgonorrheatransgendertrichomoniasis

Identifiers

PMID32366602
PMCPMC7769682
OpenAlexW3021447614

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.